Euflexxa vs Synvisc – Comparing Viscosupplements

Last Updated On: September 10, 2024

Did you know that viscosupplementation is a treatment for osteoarthritis that involves injecting hyaluronic acid into the affected joint? This naturally occurring lubricant helps reduce pain and swelling, especially in knee osteoarthritis. Euflexxa and Synvisc are two popular hyaluronic viscosupplements.

Both Euflexxa and Synvisc consist of a three-injection treatment course. While both treatments use sodium hyaluronate, they employ different methods of preparation and molecular structures, which can lead to variations in effectiveness, side effects, and patient experience.

This article explores Euflexxa and Synvisc, comparing their efficacy to help you choose the best viscosupplement for managing osteoarthritis and potentially delaying knee replacement.

Key Takeaways

• Euflexxa and Synvisc are both used to treat knee pain from osteoarthritis. Euflexxa uses pure hyaluronic acid, while Synvisc has hylan GF 20.
• People get shots of these medicines directly into the knee joint to help reduce pain and improve knee mobility.
• Both treatments can ease pain for up to six months, but doctors choose which one to use based on what works best for each patient’s body.
• Side effects from Euflexxa and Synvisc might include pain at the injection site or swelling, but these are usually not severe.
• The cost of treatment varies between Euflexxa and Synvisc, and insurance coverage can affect this choice, too.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. Buy Euflexxa at Med Supply Solutions today and stock your practice at wholesale prices!

Introduction to Euflexxa and Synvisc

Euflexxa and Synvisc are popular treatments for knee pain caused by osteoarthritis, each offering unique benefits. Euflexxa contains pure hyaluronic acid, which cushions and lubricates the joint to ease pain and enhance mobility. In contrast, Synvisc contains Hylan G-F 20, a specialized form of hyaluronic acid designed to improve joint movement and provide pain relief.

Both treatments are types of viscosupplementation involving the injection of a gel-like fluid into the knee to act as a natural lubricant, thereby reducing pain and improving function. While the effects of both treatments can last up to six months, the choice between them depends on individual needs, potential side effects, cost, and insurance coverage. 

Composition and Mechanism of Action

Euflexxa is a top choice for osteoarthritis (OA) treatment. It stands out with its formulation, which closely resembles natural joint lubricant. This helps improve joint function and reduce pain effectively. Its optimal dosage supports mobility and comfort, and its safety record makes it a preferred option over alternatives like Orthovisc or Supartz. 

Research confirms Euflexxa’s effectiveness in protecting knees from daily stresses and enhancing the quality of life for OA patients. Its minimal side effects boost confidence among both patients and healthcare providers.

Meanwhile, Synvisc enhances knee movement by providing cushion and lubrication. It’s a preferred treatment for osteoarthritis patients who haven’t found relief with primary therapies. Administered via one to three injections over several weeks, Synvisc can offer pain relief and improved joint function for up to six months. 

Its extended benefits make it a practical choice for managing knee osteoarthritis, and understanding how it compares to other treatments like Euflexxa is essential for effective OA management.

How They Assist in Knee Osteoarthritis

Euflexxa and Synvisc are effective treatments for knee osteoarthritis, providing essential joint lubrication and cushioning. Euflexxa uses pure hyaluronic acid, which mimics natural joint fluid to improve smooth movement. Similarly, Synvisc also offers benefits by injecting a lubricating fluid into the joint to enhance mobility.

Both treatments involve injections that restore the natural properties of synovial fluid, which can diminish due to osteoarthritis. These treatments effectively reduce pain and improve mobility, making daily activities easier and enhancing the overall quality of life for patients.

Clinical Efficacy and Safety Profiles

Understanding the clinical efficacy and safety profiles of Euflexxa and Synvisc is crucial for determining their suitability in treating knee osteoarthritis. It helps healthcare professionals make informed decisions tailored to individual patient needs.

Euflexxa’s Efficacy and Safety Profile

The FLEXX trial was a well-controlled study that assessed the safety and efficacy of Euflexxa therapy for knee OA over 26 weeks. In this randomized, double-blind, multicenter trial, subjects with chronic knee OA received either buffered saline (IA-SA) or IA-BioHA (Euflexxa) injections. 

The primary outcome was the difference in least-squares means between IA-BioHA and IA-SA based on a 50-foot walk test using a 100-mm visual analog scale (VAS). The IA-BioHA group showed significant pain relief, with a median reduction of 53% from baseline, compared to 38% in the IA-SA group. Secondary measures also demonstrated improvements in joint function, treatment satisfaction, and health-related quality of life.

Additionally, an open-label extension study of the FLEXX trial explored the safety and efficacy of retreatment with Euflexxa. The results indicated favorable outcomes for painful knee OA.

Synvisc’s Efficacy and Safety Profile

Medical research and clinical studies have extensively observed Synvisc’s efficacy and safety in treating knee osteoarthritis (OA). Synvisc’s clinical efficacy trials have shown that it can deliver six months of relief for chronic knee OA pain. It’s comparable in effectiveness to intra-articular corticosteroid injections, which have a quicker onset but shorter duration of action than Synvisc. 

Repeated injections of Synvisc are considered safer than corticosteroids in patients with comorbidities that may make corticosteroids contraindicated. Overall, Synvisc provides a valuable option for managing knee OA symptoms.

Practical Considerations

Euflexxa and Synvisc are used to manage osteoarthritis (OA) pain but have different treatment protocols. Medical professionals must know these differences to choose the best option for their patients.

• Pre-Treatment Evaluation: A thorough joint health assessment ensures viscosupplementation is appropriate for the patient.
• Adverse Effects: Discuss potential side effects like injection site pain, swelling, or heat with patients.
• Allergy Check: Verify bird or egg allergies before using Synvisc due to its composition.
• Choice Factors: Decide between Euflexxa and Synvisc based on injection frequency versus duration of relief.
• Injection Technique: Only trained professionals should administer treatments to ensure safety and efficacy.
• Follow-Up: Regular check-ins assess effectiveness and adjust treatment as needed.
• Insurance Coverage: Verify insurance benefits for Euflexxa and Synvisc, as coverage can impact patient choice.
• Long-Term Effectiveness: Euflexxa may need more frequent repeats, while Synvisc offers longer-lasting relief.

Patient Satisfaction and Real-World Outcomes

Patient satisfaction and actual results are crucial when comparing viscosupplements like Euflexxa vs. Hyalgan, Synvisc, Orthovisc, and others. Concrete feedback and results provide a more transparent understanding of how these treatments fare outside scientific tests.

Euflexxa is known for its pure hyaluronic acid composition and generally receives positive feedback for its pain relief and improvement in joint function. Patients appreciate its natural formulation and the relief it provides from osteoarthritis symptoms.

Synvisc, with its hyaluronan composition, is similarly well-regarded. It substantially improves joint lubrication and movement, leading to high patient satisfaction. Some patients may prefer Synvisc due to its specific formulation, which can provide longer-lasting relief for certain individuals.

Ultimately, patient satisfaction with either treatment often depends on personal experiences with pain relief, mobility improvements, and any side effects encountered. Consulting with healthcare providers can help patients choose the best option based on their needs and medical history.

Conclusion

Choosing between Euflexxa and Synvisc involves considering their different ingredients, pain relief duration, and cost. Both help ease osteoarthritis pain but in unique ways. Consulting a doctor is crucial to determine the best option based on individual needs, relief duration, and personal health.

FAQs

1. What is the difference between Euflexxa and other viscosupplements?

In dosage and administration protocols, Euflexxa, or sodium hyaluronate, differs from viscosupplements like Orthovisc, Monovisc, Supartz, and Synvisc.

2. How does Euflexxa compare to Synvisc?

Euflexxa and Synvisc address osteoarthritis knee pain but differ in formulation and prescribing details, affecting patient suitability.

3. Is there a significant difference between Euflexxa, Supartz, Euflexxa, and Hyalgan?

Yes, each product’s unique formulation influences its effectiveness and side effects. Consult a healthcare provider to determine the best option.

4. Can Euflexxa be used interchangeably with Orthovisc or Monovisc?

Despite serving similar functions, Euflexxa, Orthovisc, and Monovisc have different formulations. To avoid potential issues, consult a medical professional before interchanging them.

References

Viscosupplementation Treatment for Arthritis. www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/arthritis/viscosupplementation-treatment-for-arthritis

https://www.facebook.com/WebMD. Hyaluronan Injections for Knee Osteoarthritis. WebMD. https://www.webmd.com/osteoarthritis/hyaluronan-injections-knee